Published :
Tables : 45
Figures : 42
Category : Healthcare
No. of Pages : 200
Report Code : HC-1013
Dermal Fillers Market Introduction Global dermal fillers market is projected to value over US$ 9.2 billion by the end of 2027 and expand at a CAGR of over 13% during the forecast period of 2020-2027. Dermal fillers are injections used to fill out wrinkles and gives a smooth appearance to the skin. They can also be used to increase the volume of facial organs. They include collagen, hyaluronic acid, calcium hydroxyl apatite and others. Dermal fillers effects can be either temporary or permanent, depending on the type of fillers and used for facial reconstruction. Dermal collagen is used for triggering dermal metabolism and its effects last for three to four months. Hyaluronic acid is used for facial reappearance and its effects last for four months to six months. Calcium hydroxylapatite is used for facial augmentation and its effect last for 18 months and polymethylmethacrylate beads are used for permanent effect. The increasing importance of personal appearance in general population led to the potential growth of dermal fillers market. Along with this, rising awareness of minimally invasive cosmetic procedure led to rapid adoption. Further, changing demographics and rising living standards led to the potential growth of the market. Minimal invasive cosmetic procedures like dermal fillers more cost effects with fewer side effects compared to conventional cosmetic procedures. Dermal fillers market has witnessed double digit growth during the forecast period due to increasing penetration among developing countries. Additionally, increasing R&D investment to strengthen the product portfolio led to the development of new products in the forecast period. High awareness and penetration among the general population of developed economies like North America and Europe region account major share in global dermal fillers market. They are expected to remain dominant over the forecast period and witness stagnant growth rate. Asia Pacific is a fast growing region and expected to create an opportunistic space for both international and local manufacturers. Asia Pacific and Latin America is a fast growing region in the global Dermal Fillers market. Rest of the world is expected to account minor share in global market. Major market players include Allergan, Skin, & Vein Institute, LLC, Galderma Laboratories, L.P, Merz Pharma, Dr. Korman Laboratories, Sinclair Pharma, Teoxane Laboratories, Suneva Medical, SciVision Biotech Inc., Medytox. Dermal fillers market is expected to witness new player’s entry during the forecast period. Dermal Fillers Market Segmentation: By Filler Type Calcium hydroxylapatite Hyaluronic acid Poly-alkylimide Polylactic acid, Polymethylmethacrylate microspheres (PMMA) By Application Scar Treatment Wrinkle Correction Treatment Lip Enhancement Restoration of Volume/Fullness Others By Product Biodegradable Non-Biodegradable By End-User Hospital Cosmetic Clinics Outpatient Centres Beauty Centres Academics By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global dermal filler market on the basis of by Filler Type, by Application, by Product, by End User and By Region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and an overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Global dermal fillers market is projected to value over US$ 9.2 billion by the end of 2027 and expand at a CAGR of over 13% during the forecast period of 2020-2027.
Dermal fillers are injections used to fill out wrinkles and gives a smooth appearance to the skin. They can also be used to increase the volume of facial organs. They include collagen, hyaluronic acid, calcium hydroxyl apatite and others. Dermal fillers effects can be either temporary or permanent, depending on the type of fillers and used for facial reconstruction. Dermal collagen is used for triggering dermal metabolism and its effects last for three to four months. Hyaluronic acid is used for facial reappearance and its effects last for four months to six months. Calcium hydroxylapatite is used for facial augmentation and its effect last for 18 months and polymethylmethacrylate beads are used for permanent effect.
The increasing importance of personal appearance in general population led to the potential growth of dermal fillers market. Along with this, rising awareness of minimally invasive cosmetic procedure led to rapid adoption. Further, changing demographics and rising living standards led to the potential growth of the market. Minimal invasive cosmetic procedures like dermal fillers more cost effects with fewer side effects compared to conventional cosmetic procedures. Dermal fillers market has witnessed double digit growth during the forecast period due to increasing penetration among developing countries. Additionally, increasing R&D investment to strengthen the product portfolio led to the development of new products in the forecast period.
High awareness and penetration among the general population of developed economies like North America and Europe region account major share in global dermal fillers market. They are expected to remain dominant over the forecast period and witness stagnant growth rate. Asia Pacific is a fast growing region and expected to create an opportunistic space for both international and local manufacturers. Asia Pacific and Latin America is a fast growing region in the global Dermal Fillers market. Rest of the world is expected to account minor share in global market.
Major market players include Allergan, Skin, & Vein Institute, LLC, Galderma Laboratories, L.P, Merz Pharma, Dr. Korman Laboratories, Sinclair Pharma, Teoxane Laboratories, Suneva Medical, SciVision Biotech Inc., Medytox. Dermal fillers market is expected to witness new player’s entry during the forecast period.
Dermal Fillers Market Segmentation:
By Filler Type
By Application
By Product
By End-User
By Region
Competitive Landscape:
FutureWise Takeaways
Objectives of the Study:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Dermal Fillers Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Dermal Fillers Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Dermal Fillers Market, By Filler Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Calcium hydroxylapatite 7.2. Hyaluronic acid 7.3. Poly-alkylimide 7.4. Polylactic acid, 7.5. Polymethylmethacrylate microspheres (PMMA) 8. Global Dermal Fillers Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Scar Treatment 8.2. Wrinkle Correction Treatment 8.3. Lip Enhancement 8.4. Restoration of Volume/Fullness 8.5. Others 9. Global Dermal Fillers Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Biodegradable 9.2. Non-Biodegradable 10. Global Dermal Fillers Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Hospital 10.2. Cosmetic Clinics 10.3. Outpatient Centres 10.4. Beauty Centres 10.5. Academics 11. North America Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Switzerland 13.2.9. Rest of Western Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. Singapore 14.2.4. India 14.2.5. Australia and New Zealand 14.2.6. ASEAN 14.2.7. South Korea 14.2.8. Taiwan 14.2.9. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1. Allergan 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Skin, & Vein Institute, LLC 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Galderma Laboratories, L.P 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Merz Pharma 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Dr. Korman Laboratories 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Sinclair Pharma 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Teoxane Laboratories 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Suneva Medical 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. SciVision Biotech Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Medytox 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. Impact of COVID-19 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1. Years Considered for the Study
1.3.2. Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global Dermal Fillers Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards And Compliances
5. Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus on Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Dermal Fillers Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals And Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global Dermal Fillers Market, By Filler Type Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Calcium hydroxylapatite
7.2. Hyaluronic acid
7.3. Poly-alkylimide
7.4. Polylactic acid,
7.5. Polymethylmethacrylate microspheres (PMMA)
8. Global Dermal Fillers Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Scar Treatment
8.2. Wrinkle Correction Treatment
8.3. Lip Enhancement
8.4. Restoration of Volume/Fullness
8.5. Others
9. Global Dermal Fillers Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Biodegradable
9.2. Non-Biodegradable
10. Global Dermal Fillers Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Hospital
10.2. Cosmetic Clinics
10.3. Outpatient Centres
10.4. Beauty Centres
10.5. Academics
11. North America Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Regional Market Trends
12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.3.1. Brazil
12.3.2. Venezuela
12.3.3. Argentina
12.3.4. Rest of Latin America
12.4. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Switzerland
13.2.9. Rest of Western Europe
13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Japan
14.2.2. China
14.2.3. Singapore
14.2.4. India
14.2.5. Australia and New Zealand
14.2.6. ASEAN
14.2.7. South Korea
14.2.8. Taiwan
14.2.9. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Dermal Fillers Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
15.2.1. Saudi Arabia
15.2.2. UAE
15.2.3. South Africa
15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
16.1. Allergan
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.3. SWOT Analysis
16.1.4. Financial Overview
16.1.5. Strategic Overview
16.2. Skin, & Vein Institute, LLC
16.2.1. Company Overview
16.2.2. Product Portfolio
16.2.3. SWOT Analysis
16.2.4. Financial Overview
16.2.5. Strategic Overview
16.3. Galderma Laboratories, L.P
16.3.1. Company Overview
16.3.2. Product Portfolio
16.3.3. SWOT Analysis
16.3.4. Financial Overview
16.3.5. Strategic Overview
16.4. Merz Pharma
16.4.1. Company Overview
16.4.2. Product Portfolio
16.4.3. SWOT Analysis
16.4.4. Financial Overview
16.4.5. Strategic Overview
16.5 Dr. Korman Laboratories
16.5.1. Company Overview
16.5.2. Product Portfolio
16.5.3. SWOT Analysis
16.5.4. Financial Overview
16.5.5. Strategic Overview
16.6 Sinclair Pharma
16.6.1. Company Overview
16.6.2. Product Portfolio
16.6.3. SWOT Analysis
16.6.4. Financial Overview
16.6.5. Strategic Overview
16.7. Teoxane Laboratories
16.7.1. Company Overview
16.7.2. Product Portfolio
16.7.3. SWOT Analysis
16.7.4. Financial Overview
16.7.5. Strategic Overview
16.8. Suneva Medical
16.8.1. Company Overview
16.8.2. Product Portfolio
16.8.3. SWOT Analysis
16.8.4. Financial Overview
16.8.5. Strategic Overview
16.9. SciVision Biotech Inc.
16.9.1. Company Overview
16.9.2. Product Portfolio
16.9.3. SWOT Analysis
16.9.4. Financial Overview
16.9.5. Strategic Overview
16.10. Medytox
16.10.1. Company Overview
16.10.2. Product Portfolio
16.10.3. SWOT Analysis
16.10.4. Financial Overview
16.10.5. Strategic Overview
17. Impact of COVID-19
17.1. Positive influence on the healthcare industry
17.2. The financial disruption of the manufacturing sector
17.3. Impact of COVID-19 on emerging companies
17.4. Significant mandates in the healthcare regulations initiated by administrations
17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics